Coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA)
RxNorm 2745589
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2745589 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Coumaphos 0.03 mg/MG / propoxur 0.02 mg/MG / sulfanilamide 0.05 mg/MG Topical Powder
(Atom ID: 13060482)
PSN
Prescribable Name (PSN):
Coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA)
(Atom ID: 13060496)
SY